In vivo, in vitro toxicity and in vitro angiogenic inhibition of sunitinib malate.

Purpose: To evaluate the in vivo and in vitro toxicity of sunitinib malate, a multikinase inhibitor molecule.

Design: Experimental, Prospective, Controlled.

Methods: Human retinal pigment epithelial (ARPE-19) and human umbilical vein endothelialcells (HUVECS) were used in a culture toxicity test and exposed to different concentrations of sunitinib malate for 18 hours.